BHWA
ABBV icon

Beacon Harbor Wealth Advisors’s AbbVie ABBV Stock Holding History

Beacon Harbor Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.49M Sell
21,874
-12,911
-37% -$2.78M 1.07% 40
2026
Q1 		$7.57M Buy
34,785
+45
+0.1% +$9.98K 1.59% 31
2025
Q4 		$7.94M Sell
34,740
-236
-0.7% -$53.8K 1.76% 21
2025
Q3 		$8.1M Buy
34,976
+173
+0.5% +$35.2K 1.89% 14
2025
Q2 		$6.46M Sell
34,803
-3,321
-9% -$617K 1.61% 27
2025
Q1 		$7.99M Sell
38,124
-1,291
-3% -$251K 1.86% 16
2024
Q4 		$7M Buy
39,415
+1,225
+3% +$225K 1.63% 24
2024
Q3 		$7.54M Buy
38,190
+337
+0.9% +$62.9K 1.79% 17
2024
Q2 		$6.49M Buy
37,853
+674
+2% +$112K 1.69% 22
2024
Q1 		$6.77M Sell
37,179
-373
-1% -$64.3K 1.79% 17
2023
Q4 		$5.82M Buy
37,552
+850
+2% +$124K 1.69% 21
2023
Q3 		$5.47M Buy
36,702
+495
+1% +$72.7K 1.82% 17
2023
Q2 		$4.88M Buy
36,207
+807
+2% +$118K 1.6% 33
2023
Q1 		$5.64M Sell
35,400
-3,668
-9% -$561K 1.97% 14
2022
Q4 		$6.31M Buy
+39,068
New +$5.99M 2.15% 14
2022
Q2 		$6.01M Sell
39,241
-2,895
-7% -$442K 2.12% 15
2022
Q1 		$6.83M Buy
42,136
+2,212
+6% +$321K 2.23% 12
2021
Q4 		$5.41M Sell
39,924
-2,512
-6% -$297K 1.79% 22
2021
Q3 		$4.58M Buy
42,436
+12,058
+40% +$1.38M 1.62% 20
2021
Q2 		$3.42M Buy
30,378
+2,833
+10% +$319K 1.23% 44
2021
Q1 		$2.98M Sell
27,545
-9,534
-26% -$1.02M 1.19% 43
2020
Q4 		$3.97M Sell
37,079
-3,273
-8% -$315K 1.62% 20
2020
Q3 		$3.53M Buy
40,352
+9,079
+29% +$855K 1.72% 17
2020
Q2 		$3.07M Sell
31,273
-8,708
-22% -$767K 1.76% 23
2020
Q1 		$3.05M Buy
39,981
+12,844
+47% +$1.09M 2.3% 16
2019
Q4 		$2.4M Buy
27,137
+217
+0.8% +$18K 1.42% 28
2019
Q3 		$2.01M Buy
26,920
+1,071
+4% +$73.4K 1.28% 37
2019
Q2 		$1.88M Buy
+25,849
New +$2.03M 1.72% 26

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Beacon Harbor Wealth Advisors's ABBV Position: Q2 2026 in Review

Beacon Harbor Wealth Advisors reduced its AbbVie (ABBV) stake by 37% in Q2 2026, selling an estimated $2.78M and leaving 21,874 shares worth $5.49M. The position accounts for 1.07% of the portfolio, ranked #40.

Beacon Harbor Wealth Advisors first reported a position in ABBV in Q2 2019 and has held it in 28 quarters since. The position peaked at $8.1M in Q3 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Beacon Harbor Wealth Advisors held 21,874 shares of AbbVie worth $5.49M as of Q2 2026.
  • Beacon Harbor Wealth Advisors sold 12,911 AbbVie shares in Q2 2026, an estimated $2.78M.
  • AbbVie made up 1.07% of Beacon Harbor Wealth Advisors's portfolio in Q2 2026, its #40 holding.
  • Beacon Harbor Wealth Advisors first reported a position in AbbVie in Q2 2019 and has held it in 28 quarters since.
  • Beacon Harbor Wealth Advisors's AbbVie position peaked at $8.1M in Q3 2025.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Beacon Harbor Wealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.